🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael Nebozhyn

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0000-0001-8835-7714

Also affiliated with Applied Science Laboratories (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer”.

Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer

Gut(2024)10.1136/gutjnl-2024-332535

N/A

0.561DataRank · unranked

41 citations

Michelle Maurin, Jetsen A. Rodriguez-Silva, Gunjan Upadhyay, Ashley Alden, Siddabasave Gowda B. Gowda +24 more

Identifying distinct prognostic and predictive contributions of tumor epithelium versus tumor microenvironment in colorectal cancer

BMC Cancer(2025)10.1186/s12885-025-13829-2

N/A

0.241DataRank · unranked

4 citations

Michael Nebozhyn, Michael J. Schell, Nishant Gandhi, Lance Pflieger, Andrey Loboda +14 more

An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy

BMC Cancer(2022)10.1186/s12885-022-09344-3

N/A

0DataRank · unranked

22 citations

Thomas B. Davis, Lance Pflieger, Michael Nebozhyn, Andrey Loboda, Heiman Wang +5 more